Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS guidance · 2025-06-04

Clinical Trial Update: Ethical Issues of Using Gene Therapy in the Treatment of AMD

View source ↗

Summary

This document discusses the ethical considerations of applying gene therapy to treat age-related macular degeneration and notes the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: Exudative Age-related Macular Degeneration | Status: NOT_YET_RECRUITING